Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

NIH - National Institutes of Health National Cancer Institute Division of Cancer Treatment and Diagnosis Center for Cancer Research
NCI Experimental Therapeutics Program (NExT)
Contact NExT
Show menu
Search this site
Last Updated: 09/16/16

Lead Development NExT Projects

Applicant Institute Project
Dang, Chi University of Pennsylvania Development of FX11, a Lactate Dehydrogenase A (LDHA) Inhibitor, as an Anti-neoplastic Agent
Deshaies, Raymond California Institute of Technology Development of Small Molecule Inhibitors of the p97 AAA ATPase
Fesik, Stephen W. Vanderbilt University Medical Center Discovery of Small Molecule Inhibitors of the WDR5-MLL1 Interaction
Fesik, Stephen W. Vanderbilt University Medical Center Discovery of Subnanomolar Inhibitors of Mcl-1
Harris, Curtis Center for Cancer Research, National Cancer Institute, NIH Anti-miR-21 therapeutics to treat and prevent metastatic colon cancer